Biofarm S.A. (BVB:BIO)

Market Cap	817.85M
Revenue (ttm)	318.89M
Net Income (ttm)	88.21M
Shares Out	985.37M
EPS (ttm)	0.08
PE Ratio	10.20
Forward PE	n/a
Dividend	0.03 (3.73%)
Ex-Dividend Date	Aug 18, 2025

Volume	227,195
Average Volume	87,303
Open	0.8260
Previous Close	0.8260
Day's Range	0.8200 - 0.8300
52-Week Range	0.6200 - 0.8980
Beta	0.26
RSI	55.54
Earnings Date	Feb 27, 2026

About Biofarm

Biofarm S.A. manufactures and sells medicines in Romania. The company offers a portfolio of products covering therapeutic areas, such as antiallergics, cardiovascular and circulatory, analgesics and antipyretics, dermatology, digestive and metabolic, endocrine, genitourinary, multivitamins, ophthalmology, musculoskeletal, respiratory and ENT, and neurology. It provides prescription and non-prescription medicines, food supplements, medical devices, cosmetics, and other products. The company also exports its products in Azerbaijan, Albania, Georg...

• Industry: Pharmaceutical Preparations
• Founded: 1921
• Employees: 373
• Stock Exchange: Bucharest Stock Exchange
• Ticker Symbol: BIO

Financial Performance

In 2024, Biofarm's revenue was 286.77 million, an increase of 2.31% compared to the previous year's 280.29 million. Earnings were 74.40 million, a decrease of -3.40%.